These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31412267)

  • 1. Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways.
    Zhou JY; Poudel A; Welchko R; Mekala N; Chandramani-Shivalingappa P; Rosca MG; Li L
    Eur J Pharmacol; 2019 Oct; 861():172594. PubMed ID: 31412267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liraglutide induces beige fat development and promotes mitochondrial function in diet induced obesity mice partially through AMPK-SIRT-1-PGC1-α cell signaling pathway.
    Zhou J; Poudel A; Chandramani-Shivalingappa P; Xu B; Welchko R; Li L
    Endocrine; 2019 May; 64(2):271-283. PubMed ID: 30535743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats.
    Decara J; Rivera P; Arrabal S; Vargas A; Serrano A; Pavón FJ; Dieguez C; Nogueiras R; Rodríguez de Fonseca F; Suárez J
    Acta Physiol (Oxf); 2018 Apr; 222(4):e13008. PubMed ID: 29193738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide regulates lipid metabolism via FGF21- LKB1- AMPK- ACC1 pathway in white adipose tissues and macrophage of type 2 diabetic mice.
    Zhang N; Liu C; Zhang Y; Xu D; Gui L; Lu Y; Zhang Q
    Biochem Biophys Res Commun; 2021 Apr; 548():120-126. PubMed ID: 33640604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
    Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways.
    Luo Y; Yang P; Li Z; Luo Y; Shen J; Li R; Zheng H; Liang Y; Xia N
    Drug Des Devel Ther; 2019; 13():4065-4074. PubMed ID: 31819375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetes.
    Hao T; Zhang H; Li S; Tian H
    Int J Mol Med; 2017 Apr; 39(4):1029-1036. PubMed ID: 28290604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide promotes UCP1 expression and lipolysis of adipocytes by promoting the secretion of irisin from skeletal muscle cells.
    Zhang N; Zhou H; Xu Y; Zhang Y; Yu F; Gui L; Zhang Q; Lu Y
    Mol Cell Endocrinol; 2024 Jul; 588():112225. PubMed ID: 38570133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formononetin, an isoflavone, activates AMP-activated protein kinase/β-catenin signalling to inhibit adipogenesis and rescues C57BL/6 mice from high-fat diet-induced obesity and bone loss.
    Gautam J; Khedgikar V; Kushwaha P; Choudhary D; Nagar GK; Dev K; Dixit P; Singh D; Maurya R; Trivedi R
    Br J Nutr; 2017 Mar; 117(5):645-661. PubMed ID: 28367764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.
    Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH
    Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q; Sha S; Sun L; Zhang J; Dong M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway.
    Xin C; Liu J; Zhang J; Zhu D; Wang H; Xiong L; Lee Y; Ye J; Lian K; Xu C; Zhang L; Wang Q; Liu Y; Tao L
    Int J Obes (Lond); 2016 Mar; 40(3):443-51. PubMed ID: 26403433
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lee Y; Lee J; Lee MS; Chang E; Kim Y
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of kynurenic acid reduces hyperlipidemia-induced inflammation and insulin resistance in skeletal muscle and adipocytes.
    Jung TW; Park J; Sun JL; Ahn SH; Abd El-Aty AM; Hacimuftuoglu A; Kim HC; Shim JH; Shin S; Jeong JH
    Mol Cell Endocrinol; 2020 Dec; 518():110928. PubMed ID: 32702471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
    Han X; Ding C; Zhang G; Pan R; Liu Y; Huang N; Hou N; Han F; Xu W; Sun X
    Biochem Biophys Res Commun; 2020 May; 525(4):895-901. PubMed ID: 32171530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calebin-A inhibits adipogenesis and hepatic steatosis in high-fat diet-induced obesity via activation of AMPK signaling.
    Lai CS; Liao SN; Tsai ML; Kalyanam N; Majeed M; Majeed A; Ho CT; Pan MH
    Mol Nutr Food Res; 2015 Oct; 59(10):1883-95. PubMed ID: 26108684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
    Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
    Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.